Medicure shares MEND-PNPO Phase 3 design and baseline data at congress
Medicure announced its MEND-PNPO Phase 3 study design and baseline data at the 16th European Epilepsy Congress.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.